跳至主要内容
临床试验/NCT00209404
NCT00209404已完成4 期

Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

GE Healthcare1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2005年7月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
GE Healthcare
入组人数
50
试验地点
1
主要终点
Change in mean heart rate

研究概览

简要总结

Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaque™ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Subjects with low to moderate suspicion of coronary artery disease referred for retrospective electrocardiogram (ECG)-gated multidetector row computed tomography coronary angiography and with a heart rate >75 beats per minute (bpm) will be included.

排除标准

  • •Subjects who take medications that slow down the heart rate or present cardiac arrhythmia at rest will not be included.

结局指标

主要结局

Change in mean heart rate

次要结局

  • Image quality
  • Diagnostic quality
  • Overall diagnostic information
  • Frequency and intensity of adverse events

研究者

发起方
GE Healthcare
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Iodixanol in Multidetector-Row Computed... | 临床试验